SlideShare a Scribd company logo
1 of 22
JSM 2011  Good Statistical Practice for Medical Device Trial   Submission   Huyuan Yang † , Matthew  Rousseau* ,   H. Terry Liao * P , and Peter Lam*   †   Millennium Pharmaceutical * Boston Scientific Corporation P  Presenter The view points of this presentation are from the authors and not from the companies we represent
Outline ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Key Elements in Trial Design ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],JSM 2011
Sample Size Calculation ,[object Object],[object Object],[object Object],[object Object],[object Object],JSM 2011
Case Example 1:  Superiority RCT ,[object Object],[object Object],[object Object],[object Object],[object Object],JSM 2011
Estimate Sample Size Range JSM 2011  N per group using a 2-sided 5% alpha and 90% power Test Rate Control Rate 10% 10.25% 10.5% 10.75% 11% 5% 582 535 495 460 428 5.25% 654 599 552 510 473 5.5% 740 674 617 568 524 5.75% 842 762 694 635 583 6% 965 867 784 713 652
Estimate Power Range JSM 2011  Assessing power using a fixed N of 617/group Test Rate Control Rate 10% 10.25% 10.5% 10.75% 11% 5% 91% 93% 95% 96% 97% 5.25% 89% 90% 92% 94% 95% 5.5% 84% 87% 90% 92% 94% 5.75% 79% 83% 86% 89% 91% 6% 73% 78% 82% 85% 88%
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Case Example 2:  Non-inferiority RCT JSM 2011
Estimate Power Range JSM 2011  Assessing power using a fixed N of 592 per group with a NI margin of 7.5% Control Rate Test Rate 24% 25% 26% 27% 28% 24% 91% 83% 70% 55% 39% 25% 96% 90% 82% 69% 54% 26% 98% 95% 90% 81% 68% 27% 99% 98% 95% 89% 80% 28% 99% 99% 97% 94% 89%
Sample Size Calculation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],JSM 2011
Missing Data ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],JSM 2011
NAS report ‘Handling of Missing Data in Clinical Trials’ ,[object Object],[object Object],[object Object],[object Object],JSM 2011
Missing Data Handling ,[object Object],[object Object],[object Object],JSM 2011
Sensitivity Analyses ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],JSM 2011
Sample Size Adjustment ,[object Object],[object Object],JSM 2011
Interim Data Peek ,[object Object],[object Object],[object Object],[object Object],JSM 2011
Multiplicity ,[object Object],[object Object],[object Object],[object Object],[object Object],JSM 2011
Site Pooling ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],JSM 2011
Poolability Across Sites ,[object Object],[object Object],[object Object],JSM 2011
Poolablility Not Justified ,[object Object],[object Object],[object Object],JSM 2011
Summary ,[object Object],[object Object],[object Object],[object Object],[object Object]
reference ,[object Object],[object Object],[object Object],[object Object],JSM 2011

More Related Content

What's hot

audit sampling notes
audit sampling notesaudit sampling notes
audit sampling notes
student
 
Audit sampling
Audit samplingAudit sampling
Audit sampling
zaur2009
 
Dragalin Flexible Design
Dragalin Flexible DesignDragalin Flexible Design
Dragalin Flexible Design
heominkyu
 
Sample size
Sample sizeSample size
Sample size
zubis
 
Biomarker discovery and validation
Biomarker discovery and validationBiomarker discovery and validation
Biomarker discovery and validation
Winton Gibbons
 
4 primaryresearchquestionanddefinitionofendpointsindia2007
4 primaryresearchquestionanddefinitionofendpointsindia20074 primaryresearchquestionanddefinitionofendpointsindia2007
4 primaryresearchquestionanddefinitionofendpointsindia2007
KhanhHoa Tran
 

What's hot (20)

audit sampling notes
audit sampling notesaudit sampling notes
audit sampling notes
 
SA 530 Audit Sampling
SA 530 Audit SamplingSA 530 Audit Sampling
SA 530 Audit Sampling
 
Journal for Clinical Studies: Close Cooperation Between Data Management and B...
Journal for Clinical Studies: Close Cooperation Between Data Management and B...Journal for Clinical Studies: Close Cooperation Between Data Management and B...
Journal for Clinical Studies: Close Cooperation Between Data Management and B...
 
Efficient Data Reviews and Quality in Clinical Trials - Kelci Miclaus
Efficient Data Reviews and Quality in Clinical Trials - Kelci MiclausEfficient Data Reviews and Quality in Clinical Trials - Kelci Miclaus
Efficient Data Reviews and Quality in Clinical Trials - Kelci Miclaus
 
Data mining for diabetes readmission
Data mining for diabetes readmissionData mining for diabetes readmission
Data mining for diabetes readmission
 
Harmonization of Laboratory Testing, 08 04-2017
Harmonization of Laboratory Testing, 08 04-2017Harmonization of Laboratory Testing, 08 04-2017
Harmonization of Laboratory Testing, 08 04-2017
 
Audit sampling
Audit samplingAudit sampling
Audit sampling
 
Automation Extraction of Side Effect Information from Consumer drug reviews
Automation Extraction of Side Effect Information from Consumer drug reviewsAutomation Extraction of Side Effect Information from Consumer drug reviews
Automation Extraction of Side Effect Information from Consumer drug reviews
 
Root Cause Analysis – A Practice to Understanding and Control the Failure Man...
Root Cause Analysis – A Practice to Understanding and Control the Failure Man...Root Cause Analysis – A Practice to Understanding and Control the Failure Man...
Root Cause Analysis – A Practice to Understanding and Control the Failure Man...
 
Bioanalytical validation house of cards
Bioanalytical validation house of cardsBioanalytical validation house of cards
Bioanalytical validation house of cards
 
Dragalin Flexible Design
Dragalin Flexible DesignDragalin Flexible Design
Dragalin Flexible Design
 
Sample size
Sample sizeSample size
Sample size
 
Adaptive Clinical Trials: Role of Modelling and Simulation
Adaptive Clinical Trials: Role of Modelling and Simulation Adaptive Clinical Trials: Role of Modelling and Simulation
Adaptive Clinical Trials: Role of Modelling and Simulation
 
Biomarker discovery and validation
Biomarker discovery and validationBiomarker discovery and validation
Biomarker discovery and validation
 
2010 JSM - Meta Stat Issue Medical Devices
2010 JSM - Meta Stat Issue Medical Devices2010 JSM - Meta Stat Issue Medical Devices
2010 JSM - Meta Stat Issue Medical Devices
 
What is the EU-regulatory point of view on non-inferiority trials?
What is the EU-regulatory point of view on non-inferiority trials?What is the EU-regulatory point of view on non-inferiority trials?
What is the EU-regulatory point of view on non-inferiority trials?
 
Clinical Trial Simulation training with simulo 20161124
Clinical Trial Simulation training with simulo 20161124Clinical Trial Simulation training with simulo 20161124
Clinical Trial Simulation training with simulo 20161124
 
Research
ResearchResearch
Research
 
Multivariatetechniques01
Multivariatetechniques01Multivariatetechniques01
Multivariatetechniques01
 
4 primaryresearchquestionanddefinitionofendpointsindia2007
4 primaryresearchquestionanddefinitionofendpointsindia20074 primaryresearchquestionanddefinitionofendpointsindia2007
4 primaryresearchquestionanddefinitionofendpointsindia2007
 

Viewers also liked

Power and Electrical Safety in Hospitals
Power and Electrical Safety in HospitalsPower and Electrical Safety in Hospitals
Power and Electrical Safety in Hospitals
Suhas Deshpande
 
IOL power calculation formulae
IOL power calculation formulaeIOL power calculation formulae
IOL power calculation formulae
pujarai
 
Medical Electrical Safety
Medical Electrical SafetyMedical Electrical Safety
Medical Electrical Safety
Ismail Yusof
 

Viewers also liked (13)

Capsule Corporate Overview
Capsule Corporate OverviewCapsule Corporate Overview
Capsule Corporate Overview
 
Feature Analysis of Estimated Causes of Failures in Medical Device Software a...
Feature Analysis of Estimated Causes of Failures in Medical Device Software a...Feature Analysis of Estimated Causes of Failures in Medical Device Software a...
Feature Analysis of Estimated Causes of Failures in Medical Device Software a...
 
8.Calculate samplesize for clinical trials (continuous outcome)
8.Calculate samplesize for clinical trials (continuous outcome)8.Calculate samplesize for clinical trials (continuous outcome)
8.Calculate samplesize for clinical trials (continuous outcome)
 
Iol power calculation normal and post lasik eyes
Iol power calculation normal and post lasik eyesIol power calculation normal and post lasik eyes
Iol power calculation normal and post lasik eyes
 
Advances in iol calculation
Advances in iol calculationAdvances in iol calculation
Advances in iol calculation
 
Understanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical DevicesUnderstanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical Devices
 
Sample size calculation - a brief overview
Sample size calculation - a brief overviewSample size calculation - a brief overview
Sample size calculation - a brief overview
 
Power and Electrical Safety in Hospitals
Power and Electrical Safety in HospitalsPower and Electrical Safety in Hospitals
Power and Electrical Safety in Hospitals
 
IOL power calculation formulae
IOL power calculation formulaeIOL power calculation formulae
IOL power calculation formulae
 
Laser Therapy Power Point
Laser Therapy Power PointLaser Therapy Power Point
Laser Therapy Power Point
 
IOL power calculation special situations
IOL power calculation special situations IOL power calculation special situations
IOL power calculation special situations
 
25 Most Interesting Medical MEMS and Sensors Projects
25 Most Interesting Medical MEMS and Sensors Projects25 Most Interesting Medical MEMS and Sensors Projects
25 Most Interesting Medical MEMS and Sensors Projects
 
Medical Electrical Safety
Medical Electrical SafetyMedical Electrical Safety
Medical Electrical Safety
 

Similar to 2011 JSM - Good Statistical Practices

D6 transforming oncology development with adaptive studies - 2011-04
D6   transforming oncology development with adaptive studies - 2011-04D6   transforming oncology development with adaptive studies - 2011-04
D6 transforming oncology development with adaptive studies - 2011-04
therealreverendbayes
 
East sample size re estimation
East sample size re estimationEast sample size re estimation
East sample size re estimation
Cytel
 
Infosheet east-sample-size-re-estimation
Infosheet east-sample-size-re-estimationInfosheet east-sample-size-re-estimation
Infosheet east-sample-size-re-estimation
Cytel USA
 
Extending A Trial’s Design Case Studies Of Dealing With Study Design Issues
Extending A Trial’s Design Case Studies Of Dealing With Study Design IssuesExtending A Trial’s Design Case Studies Of Dealing With Study Design Issues
Extending A Trial’s Design Case Studies Of Dealing With Study Design Issues
nQuery
 
Eugm 2011 pocock - dm cs-and-adaptive-trials
Eugm 2011   pocock - dm cs-and-adaptive-trialsEugm 2011   pocock - dm cs-and-adaptive-trials
Eugm 2011 pocock - dm cs-and-adaptive-trials
Cytel USA
 
1Big Data Analytics forHealthcareChandan K. ReddyD.docx
1Big Data Analytics forHealthcareChandan K. ReddyD.docx1Big Data Analytics forHealthcareChandan K. ReddyD.docx
1Big Data Analytics forHealthcareChandan K. ReddyD.docx
aulasnilda
 

Similar to 2011 JSM - Good Statistical Practices (20)

5 essential steps for sample size determination in clinical trials slideshare
5 essential steps for sample size determination in clinical trials   slideshare5 essential steps for sample size determination in clinical trials   slideshare
5 essential steps for sample size determination in clinical trials slideshare
 
Sample Size Estimation and Statistical Test Selection
Sample Size Estimation  and Statistical Test SelectionSample Size Estimation  and Statistical Test Selection
Sample Size Estimation and Statistical Test Selection
 
D6 transforming oncology development with adaptive studies - 2011-04
D6   transforming oncology development with adaptive studies - 2011-04D6   transforming oncology development with adaptive studies - 2011-04
D6 transforming oncology development with adaptive studies - 2011-04
 
Overview Of Ich New E9
Overview Of Ich New E9Overview Of Ich New E9
Overview Of Ich New E9
 
Innovative sample size methods for adaptive clinical trials webinar web ver...
Innovative sample size methods for adaptive clinical trials webinar   web ver...Innovative sample size methods for adaptive clinical trials webinar   web ver...
Innovative sample size methods for adaptive clinical trials webinar web ver...
 
East sample size re estimation
East sample size re estimationEast sample size re estimation
East sample size re estimation
 
East Sample Size Re-Estimation Infosheet
East Sample Size Re-Estimation InfosheetEast Sample Size Re-Estimation Infosheet
East Sample Size Re-Estimation Infosheet
 
Infosheet east-sample-size-re-estimation
Infosheet east-sample-size-re-estimationInfosheet east-sample-size-re-estimation
Infosheet east-sample-size-re-estimation
 
2020 trends in biostatistics what you should know about study design - slid...
2020 trends in biostatistics   what you should know about study design - slid...2020 trends in biostatistics   what you should know about study design - slid...
2020 trends in biostatistics what you should know about study design - slid...
 
26738157 sampling-design
26738157 sampling-design26738157 sampling-design
26738157 sampling-design
 
Innovative Strategies For Successful Trial Design - Webinar Slides
Innovative Strategies For Successful Trial Design - Webinar SlidesInnovative Strategies For Successful Trial Design - Webinar Slides
Innovative Strategies For Successful Trial Design - Webinar Slides
 
E178.13738
E178.13738E178.13738
E178.13738
 
Prague 02.10.2008
Prague 02.10.2008Prague 02.10.2008
Prague 02.10.2008
 
Extending A Trial’s Design Case Studies Of Dealing With Study Design Issues
Extending A Trial’s Design Case Studies Of Dealing With Study Design IssuesExtending A Trial’s Design Case Studies Of Dealing With Study Design Issues
Extending A Trial’s Design Case Studies Of Dealing With Study Design Issues
 
Clinical Research Statistics for Non-Statisticians
Clinical Research Statistics for Non-StatisticiansClinical Research Statistics for Non-Statisticians
Clinical Research Statistics for Non-Statisticians
 
ICU Patient Deterioration Prediction : A Data-Mining Approach
ICU Patient Deterioration Prediction : A Data-Mining ApproachICU Patient Deterioration Prediction : A Data-Mining Approach
ICU Patient Deterioration Prediction : A Data-Mining Approach
 
ICU PATIENT DETERIORATION PREDICTION: A DATA-MINING APPROACH
ICU PATIENT DETERIORATION PREDICTION: A DATA-MINING APPROACHICU PATIENT DETERIORATION PREDICTION: A DATA-MINING APPROACH
ICU PATIENT DETERIORATION PREDICTION: A DATA-MINING APPROACH
 
Eugm 2011 pocock - dm cs-and-adaptive-trials
Eugm 2011   pocock - dm cs-and-adaptive-trialsEugm 2011   pocock - dm cs-and-adaptive-trials
Eugm 2011 pocock - dm cs-and-adaptive-trials
 
1Big Data Analytics forHealthcareChandan K. ReddyD.docx
1Big Data Analytics forHealthcareChandan K. ReddyD.docx1Big Data Analytics forHealthcareChandan K. ReddyD.docx
1Big Data Analytics forHealthcareChandan K. ReddyD.docx
 
SAPC north 2010 - provider incentives for influenza immunisation
SAPC north 2010 - provider incentives for influenza immunisationSAPC north 2010 - provider incentives for influenza immunisation
SAPC north 2010 - provider incentives for influenza immunisation
 

Recently uploaded

ابو ظبي اعلان | - سايتوتك في الامارات حبوب الاجهاض للبيع ف حبوب الإجهاض ... ا...
ابو ظبي اعلان | - سايتوتك في الامارات حبوب الاجهاض للبيع ف حبوب الإجهاض ... ا...ابو ظبي اعلان | - سايتوتك في الامارات حبوب الاجهاض للبيع ف حبوب الإجهاض ... ا...
ابو ظبي اعلان | - سايتوتك في الامارات حبوب الاجهاض للبيع ف حبوب الإجهاض ... ا...
brennadilys816
 
Constitution of Company Article of Association
Constitution of Company Article of AssociationConstitution of Company Article of Association
Constitution of Company Article of Association
seri bangash
 
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODF
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODFRATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODF
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODF
CaitlinCummins3
 
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot ReportFuture of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Dubai Multi Commodity Centre
 
Presentation4 (2) survey responses clearly labelled
Presentation4 (2) survey responses clearly labelledPresentation4 (2) survey responses clearly labelled
Presentation4 (2) survey responses clearly labelled
CaitlinCummins3
 

Recently uploaded (20)

Progress Report - UKG Analyst Summit 2024 - A lot to do - Good Progress1-1.pdf
Progress Report - UKG Analyst Summit 2024 - A lot to do - Good Progress1-1.pdfProgress Report - UKG Analyst Summit 2024 - A lot to do - Good Progress1-1.pdf
Progress Report - UKG Analyst Summit 2024 - A lot to do - Good Progress1-1.pdf
 
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptx
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptxBlinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptx
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptx
 
Innomantra Viewpoint - Building Moonshots : May-Jun 2024.pdf
Innomantra Viewpoint - Building Moonshots : May-Jun 2024.pdfInnomantra Viewpoint - Building Moonshots : May-Jun 2024.pdf
Innomantra Viewpoint - Building Moonshots : May-Jun 2024.pdf
 
ابو ظبي اعلان | - سايتوتك في الامارات حبوب الاجهاض للبيع ف حبوب الإجهاض ... ا...
ابو ظبي اعلان | - سايتوتك في الامارات حبوب الاجهاض للبيع ف حبوب الإجهاض ... ا...ابو ظبي اعلان | - سايتوتك في الامارات حبوب الاجهاض للبيع ف حبوب الإجهاض ... ا...
ابو ظبي اعلان | - سايتوتك في الامارات حبوب الاجهاض للبيع ف حبوب الإجهاض ... ا...
 
Elevate Your Online Presence with SEO Services
Elevate Your Online Presence with SEO ServicesElevate Your Online Presence with SEO Services
Elevate Your Online Presence with SEO Services
 
Exploring-Pipe-Flanges-Applications-Types-and-Benefits.pptx
Exploring-Pipe-Flanges-Applications-Types-and-Benefits.pptxExploring-Pipe-Flanges-Applications-Types-and-Benefits.pptx
Exploring-Pipe-Flanges-Applications-Types-and-Benefits.pptx
 
MichaelStarkes_UncutGemsProjectSummary.pdf
MichaelStarkes_UncutGemsProjectSummary.pdfMichaelStarkes_UncutGemsProjectSummary.pdf
MichaelStarkes_UncutGemsProjectSummary.pdf
 
Toyota Kata Coaching for Agile Teams & Transformations
Toyota Kata Coaching for Agile Teams & TransformationsToyota Kata Coaching for Agile Teams & Transformations
Toyota Kata Coaching for Agile Teams & Transformations
 
The Risks of Ignoring Bookkeeping in Your Business
The Risks of Ignoring Bookkeeping in Your BusinessThe Risks of Ignoring Bookkeeping in Your Business
The Risks of Ignoring Bookkeeping in Your Business
 
Top^Clinic ^%[+27785538335__Safe*Women's clinic//Abortion Pills In Harare
Top^Clinic ^%[+27785538335__Safe*Women's clinic//Abortion Pills In HarareTop^Clinic ^%[+27785538335__Safe*Women's clinic//Abortion Pills In Harare
Top^Clinic ^%[+27785538335__Safe*Women's clinic//Abortion Pills In Harare
 
Constitution of Company Article of Association
Constitution of Company Article of AssociationConstitution of Company Article of Association
Constitution of Company Article of Association
 
Series A Fundraising Guide (Investing Individuals Improving Our World) by Accion
Series A Fundraising Guide (Investing Individuals Improving Our World) by AccionSeries A Fundraising Guide (Investing Individuals Improving Our World) by Accion
Series A Fundraising Guide (Investing Individuals Improving Our World) by Accion
 
Guide to Networking Essentials 8th Edition by Greg Tomsho solution manual.doc
Guide to Networking Essentials 8th Edition by Greg Tomsho solution manual.docGuide to Networking Essentials 8th Edition by Greg Tomsho solution manual.doc
Guide to Networking Essentials 8th Edition by Greg Tomsho solution manual.doc
 
Global Internal Audit Standards 2024.pdf
Global Internal Audit Standards 2024.pdfGlobal Internal Audit Standards 2024.pdf
Global Internal Audit Standards 2024.pdf
 
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODF
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODFRATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODF
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODF
 
The Truth About Dinesh Bafna's Situation.pdf
The Truth About Dinesh Bafna's Situation.pdfThe Truth About Dinesh Bafna's Situation.pdf
The Truth About Dinesh Bafna's Situation.pdf
 
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot ReportFuture of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
 
Presentation4 (2) survey responses clearly labelled
Presentation4 (2) survey responses clearly labelledPresentation4 (2) survey responses clearly labelled
Presentation4 (2) survey responses clearly labelled
 
Hyundai capital 2024 1q Earnings release
Hyundai capital 2024 1q Earnings releaseHyundai capital 2024 1q Earnings release
Hyundai capital 2024 1q Earnings release
 
Daftar Rumpun, Pohon, dan Cabang Ilmu (2024).pdf
Daftar Rumpun, Pohon, dan Cabang Ilmu (2024).pdfDaftar Rumpun, Pohon, dan Cabang Ilmu (2024).pdf
Daftar Rumpun, Pohon, dan Cabang Ilmu (2024).pdf
 

2011 JSM - Good Statistical Practices

  • 1. JSM 2011 Good Statistical Practice for Medical Device Trial Submission Huyuan Yang † , Matthew Rousseau* , H. Terry Liao * P , and Peter Lam* † Millennium Pharmaceutical * Boston Scientific Corporation P Presenter The view points of this presentation are from the authors and not from the companies we represent
  • 2.
  • 3.
  • 4.
  • 5.
  • 6. Estimate Sample Size Range JSM 2011 N per group using a 2-sided 5% alpha and 90% power Test Rate Control Rate 10% 10.25% 10.5% 10.75% 11% 5% 582 535 495 460 428 5.25% 654 599 552 510 473 5.5% 740 674 617 568 524 5.75% 842 762 694 635 583 6% 965 867 784 713 652
  • 7. Estimate Power Range JSM 2011 Assessing power using a fixed N of 617/group Test Rate Control Rate 10% 10.25% 10.5% 10.75% 11% 5% 91% 93% 95% 96% 97% 5.25% 89% 90% 92% 94% 95% 5.5% 84% 87% 90% 92% 94% 5.75% 79% 83% 86% 89% 91% 6% 73% 78% 82% 85% 88%
  • 8.
  • 9. Estimate Power Range JSM 2011 Assessing power using a fixed N of 592 per group with a NI margin of 7.5% Control Rate Test Rate 24% 25% 26% 27% 28% 24% 91% 83% 70% 55% 39% 25% 96% 90% 82% 69% 54% 26% 98% 95% 90% 81% 68% 27% 99% 98% 95% 89% 80% 28% 99% 99% 97% 94% 89%
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.

Editor's Notes

  1. JSM 2007